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Abstract 
Background: 
Iron is an essential element for the human body. Iron-dependent 
free radicals formation has been related to greater damage in 
cerebral ischemia. This study analysed whether increased body 
iron stores measured as serum ferritin, were associated with 
early neurologic worsening on the outcome in patients with 
acute ischemic stroke. 
MATERIALS AND METHODS:  
This was a cross sectional study (prospective) in which 60 
patients who had acute ischemic stroke was included for study. 
Those patients who got admitted within 24 hours of stroke onset 
only were taken for study .The data of each patient will be 
collected on a proforma specially designed for this study and 
which includes demographic details, clinical features, past 
medical history, clinical and Lab values which will be analysed 
for statistical significance and correlation. Clinical status was 
determined by the NIHSS scale at admission and by MRS scale 
4 weeks later. Serum ferritin levels were assayed on admission. 
RESULTS: 
Among 60 patients 35 patients had high serum ferritin  [ ≥ 300 
mg/l (male) , ≥200 mg/ml (female ) ] and 25 patients had normal 
ferritin value. Out of these 35 cases that have high serum 
ferritin, 37.14% of cases come under moderate category and 
62.86% cases come under severe category. On the other hand, 
among the remaining 25 cases who had normal serum ferritin, 
all the 22 cases come under moderate group and none in severe 
group. Pearson’s r correlation also reveals positive correlation 
between serum ferritin   and NIHSS scores. Pearson’s r value is 
0.613. A positive correlation exists between these 2 variables 
with a statistically significant ‘p’ value. Out of 35 cases with 
high serum ferritin, 5 cases were in good outcome category and 
30 cases in poor outcome category of MRS scores. In contrast 
among 25 cases with normal serum ferritin, 17 cases were in 
good outcome (MRS) and 8 cases were in poor outcome (MRS). 
Pearson’s r correlation analysis reveals positive correlation 
between serum ferritin and MRS. Pearson’s r value is 0.560 and 
is positive variable. Any increase or decrease in serum ferritin 
score analogous linearly with increase/decrease severity score of 
NIHSS. Increase in serum ferritin will favors the poor outcome 
of patients in terms of death and severe disability. 
Conclusions:  
High ferritin  concentration  within the first 24 hours from the 
onset of ischemic stroke are associated with early neurologic 
deterioration. Increased body iron stores may contribute to 
stroke progression by enhancing the cytotoxic mechanisms in 
cerebral ischemia. More research is needed to determine the 
origin of increased serum ferritin levels and the therapeutic 
implications. Antioxidants can be added as a part of treatment 
protocol in patients with Acute Ischemic stroke. Drugs like 
Desferroxamine can be used to reduce serum ferritin levels. 
KEY WORDS: 
 ferritin 
 ischemic stroke 
 NIHSS,MRS 
 prognosis  
 Stroke outcome. 
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INTRODUCTION 
Stroke is now considered as an important health problem for all individuals 
and society. After Acute Myocardial Infarction and malignancy, Ischemic stroke is 
the third leading cause of death and also leading cause of hospitalization causing 
disability. With the advent of promising therapies, acute ischemic stroke has a 
higher expectation for rapid recovery and good outcome. Despite new therapies, 
poor outcome may still occur because ischemic stroke is a heterogeneous disease 
in which outcome is influenced by many factors. The extent of brain Injury and the 
resultant outcome from ischemia is largely dictated at a physiological level by the 
severity and duration of the ischemia.The  risk factors namely blood pressure (BP), 
smoking, diabetes, dyslipidemia and alcohol predict the happening of strokebut 
still they are not completely reliable, therefore there is a continuous debate and 
search for prediction of occurrence of stroke  and reliability of  prognostic markers 
in stroke have gained interest in recent years.  
 
In recent years, inflammatory process plays an important role in pathophysiology 
of stroke. When an individual is exposed to any insult in terms of infection and 
injury, there is a production of proteins called Acute Phase Proteins. This Acute 
phase protein participates in all inflammatory process and plays a major role in 
both acute and chronic inflammatory states. The Acute phase reactants are 
10 
 
fibrinogen, ferritin,haptoglobin, highly sensitive C – reactive protein, 
Complements (C3), Complements (C4), Tumor necrosis factor. For a longtime 
serum ferritin was measured only to know the stored iron status. Now it has been 
suggested that it influences the prognosis of ischemic stroke
1 
and also acts as a risk 
factor for ischemic episodes by enhancing atherogenesis.
2/3  
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AIM & OBJECTIVE 
 
1)  To analyze the prognostic significance of serum ferritin with severity of  
 Stroke in correlation with stroke scales (NIHSS and MRS).  
 
2) To study the relationship between serum ferritin and various risk factors 
for Stroke.  
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REVIEW OF LITERATURE 
 
As per  World Health Organization , Stroke is defined  as a clinical syndrome 
consisting of 'rapidly developing clinical signs of focal (at times global) 
disturbance of cerebral function, with duration lasting more than 24 hours or 
leading to death with no apparent cause other than that of vascular origin'. A 
transient ischemic attack (TIA) is defined as stroke symptoms and signs that 
resolve within 24 hours.  The above definition do not include retinal symptoms 
(sudden onset of monocular loss), which should be considered as part of the 
definition of stroke and TIA. A non-disabling stroke is defined as a stroke with 
symptoms that last formore than 24hours but later resolve, without any 
permanentdisability. This definition includes stroke due to cerebral infarction, 
Primaryintracerebralhemorrhage (PICH), intraventricularhemorrhage, and 
subarachnoidhemorrhage (SAH); it excludes infarction caused by 
infection,tumor,subdural hemorrhage, and epidural hemorrhage. 
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EPIDEMIOLOGY 
It is the second commonest cause of death and fourth leading cause of disability 
worldwide
4
. In United States, stroke remains the most common cause for disability, 
second most common cause of dementia and third most common cause of death. 
Stroke also predisposes to epilepsy, depression and falls
5
.It isthe leading cause of 
functional impairments, among these, 20% of survivors of stroke require 
institutional careafter 3 months and 15% - 30% of them were being permanently 
disabled
6. 
According to the World Health Organization (WHO), 15 million people 
suffer stroke worldwide each year. Among them5 million deaths were reported and 
5 million were permanently disabled
7
.
 
TABLE 1 Morbidity and Mortality of stroke
8
 
  Global Stroke India 
1. Strokes per 100,000 400-800 55.6 
2. Million deaths 5.7  0.63  
3. Million new acute 
strokes every year 
15  1.44-1.64  
4. DALYs (disability 
adjusted life-year) 
28,500,000  6,398,000 DALYs  
5. Case fatality rate 17%-35%  18-41%   
 
 
14 
 
As per Indian Council Medical Research (ICMR) reports, Stroke and  
Diabetes together brings the estimated national economic loss of approximately 46 
billion dollars in India between 2006 to 2015. India’s growth of grossdomestic 
product (GDP) is estimated to fall by 1% 
8
.
 
. 
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CLASSIFICATION OF STROKE 
9
 
 
Stroke can be classified in different ways.  
 
Based on Clinical features 
10 
 
1. Completed stroke. 
 
2. Stroke in Evolution. 
 
3. Transient Ischemic Effects. 
 
4. Reversible Ischemic Neurological Deficit. 
 
Based on Anatomical Location 
 
1. By vascular supply  
 
a. Carotid artery  
 
b. Vertebrobasilar artery  
 
2. By location  
 
a. Supra-tentorial which includes lobar and Capsulo-gangilionic 
 
b. Infra-tentorial which includes brainstem and cerebellum  
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3. By pathology  
 
 
 
4. Based on Etiology
3
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TABLE 2 ETIOLOGIES 
 
1. 
 
Thrombosis 
 
i. Large vessels disease 
ii.lacunar stroke (smallVessels) 
iii.Dehydration 
 
 
  
5. 
 
Cardiogenic  
 
i. Marantic Endocarditis 
ii. Libman sacks Endocarditis 
iii.Intracardiac mass 
iv.Mitral valve calcification 
v.Atrialmyxoma 
 
2. 
 
Embolic Occlusion 
 
i.Cardio –embolic  
a. Myocardial infarction  
b.Mural thrombus  
c.Atrial fibrillation 
ii.Dilated cardiomyopathy  
 
6. 
 
Vasculitis 
 
i.  Primary CNS vasculitis 
ii. Systemic Vasculitis – 
1.Wegener’sGranulomatosis 
2.Polyarteritis nodasa 
3.Takayasu arteritis  
4.. Giant cell arteritis 
3. Valvular lesions  
i.Mechanicalvalves 
ii.Mitralstenosis 
iii.Bacterial Endocarditis 
iv.Atria septal aneurysm 
v.Spontaneous ECHO contrast 
vi.Paradoxical embolus: 
PatentForamen ovale, Atrialseptal 
defect 
7. Meningitis 
(Tuberculosis, syphilis, bacterial, 
fungal, Bacterial, Zoster) 
18 
 
 
4. 
 
Artery to Artery 
 
a.Aortic arch 
b.Carotid artery bifurcation 
c.Arterial dissection 
 
8. 
 
Hypercoagulable disorders 
 
i.Antiphospholipid Antibody 
Syndrome 
ii.Protein C,S deficiency 
iii.Antithrombi III deficiency 
iv.Prothrombin v G20210 mutation  
vi.Systemic lupus erythematosis 
vii.Thrombotic thrombocytopenic 
Purpura 
viii.Disseminated Intravascular 
coagulation 
x. Systemic Malignancy 
xi.Inflammatory bowel disease 
xii.OralContraceptive pills 
xiii.Homocysteinemia. 
xi. Dysproteinemias 
   
9. 
 
Eclampsia,Moyamoya disease 
 
   
10. 
 
Drugs –cocaine, Amphetamine 
 
   
11. 
 
Subarachnoid hemorrhage  
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TABLE 3 RISK FACTORS
12
 
 
 
 
  
            IRREVERSIBLE  
  
          MODIFIABLE  
1. 
 
2. 
 
 
3. 
 
 
 
4. 
 
 
 
5. 
 
6. 
 
 
Age 
 
Sex ( male > female, not applicable in  
very young and very old ) 
 
Hereditary 
 
 
 
Race (Africo-carribean population 
>Asian  population> European 
population) 
 
 
History of migraine headaches 
 
Fibro muscular dysplasia 
 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
7. 
 
 
8. 
 
 
 
 
 
 
 
 
 
 
9. 
 
10. 
 
11. 
Raised Blood Sugar  
 
Hypercholesterolemia  
 
Elevated Blood pressure  
 
Smoking  
 
Sickle cell Anemia 
 
Polycythemia  
 
Excessive consumption of 
alcohol  
 
Cardiac Causes  
       1. Atrial fibrillation  
       2. Infective endocarditis 
       3.Heart Failure   
       4.Hypertrophy of left     
ventricle  
       5.Recent myocardial 
infarction  
       6.Congenital heart disease 
and malformations  
7. Mitral stenosis  
Oral contraceptive pills  
 
Physical inactivity  
 
Head and neck injuries 
20 
 
AGE:  
Age is the single most powerful risk factor for cerebral infarction. Incidence of 
stroke increases with increasing age , doubling or tripling with every decade after 
the fifth 
13
 . 
 
SEX:  
Men are more commonly affected with stroke than women. Young stroke is more 
common in young female using oral contraceptive pills and in pregnant 
individuals. Mortality rates for men are 23% to 115% higher than for women in all 
countries
14 
. 
RACE:  
The occurrence of ischemic stroke is more common among the Asians and Blacks. 
There is generally a higher incidence of all stroke types and cerebral infarction in 
blacks
15.
 
HYPERTENSION:  
 
The risk of stroke is increased four to six times in hypertensive patients. Since 
hypertension promotes the atheroma formation in all sized vessels of brain, 
hypertension is considered as important risk factor for stroke. Prolonged treatment 
of diastolic BP to produce a fall of 6mm Hg decrease the stroke risk by 40% and 
the benefits occur within 3 years
16 
.  
21 
 
DIABETES:  
Diabetic individuals are three times more prone for than individuals who are not 
diabetic. Diabetes also promotes the atheroma formation, thereby increasing the 
rate of occlusion of intracranial arteries. Impaired glucose tolerance may be a risk 
factor and elevated glycosylated hemoglobin may be found in up to 42% patients 
with cerebral infarcts not previously known to have diabetes. 
SMOKING:  
Smoking increases the stroke risk by two times. Smoking causes vasoconstriction, 
increases fibrinogen concentration, causes polycythemia, reduces aggregation of 
platelets, all these contributes stroke occurrence. There is a dose response 
relationship, the risk doubling in the heaviest of smokers
17
. In the Framingham 
study, cessation of smoking removed the additional risk of stroke within 2 years. 
ALCOHOL:  
High Alcohol Consumption increases the risk of stroke. There is evidence for an 
association between sudden heavy drinking and the onset of cerebral infarction in 
young adults
18. 
Chronic light alcohol intake is associated with a decreased risk of 
stroke
17
. Chronic heavy consumption 180 – 400 g/wk is associated with an 
increased risk. 
Transient Ischemic Attacks  
The incidence of stroke increases after TIA. The relative risk of stroke after TIA is 
13.4 in the first 12 months and 7 over first 7 years 
19
. 
22 
 
 
 
TABLE 4 Syndromes of cerebral infarction
20
 
 
Carotid Artery occlusion 
 
1. Amarouxfugax which is also known as transient monocular blindness. 
2. Speech disorder  
3. UMN type of facial palsy  
4. Loss of sensation in one half of the body(cortical type of sensory loss)  
5. Weakness of one half of the body. 
6. Hemianopia 
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Anterior cerebral artery Infarct23 
Relation to 
anterior 
communicating 
Artery 
 
Distal (peripheral ) 
 
Proximal 
 
1. 
 
Contralateral hemiplegic Hemi 
sensory loss with predominant 
lower limb involvement  
 
Complete hemiplegia   
 
2. 
 
No facial involvement  
 
 
 
Facial involvement on the 
opposite side of the body with or 
without aphasia 
 
3. 
 
Urinary incontinence  
 
 
4. 
 
Emotional disturbances  
 
 
5. 
 
Presence of released reflexes 
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Middle cerebral artery stroke 
 
Occlusion of Stem of 
Middle cerebral artery 
 
Occlusion of proximal 
superior division of 
MCA 
 
Occlusion of Inferior 
division of MCA. 
 
a. Global aphasia  
 
a. Motor weakness,  
 
a.Wernicke’s aphasia 
without weakness  
 
b. Contralateralhemiplegia 
 
B.Sensory disturbances. 
 
B.Quadrantopsia 
sometimes. 
 
c. Contralateral 
hemianaesthesia 
 
c.Motor aphasia 
 
c.Innon dominant 
hemisphere, hemi neglect 
and spatial agnosia can 
occur without weakness.  
 
d. Contra lateral hemianopia  
  
e. Apractagnosia, dysarthria, 
contra lateral neglect in non 
dominant hemisphere 
involvement. 
  
The MCA supplies the upper extremity motor strip. So weakness of the arm and 
face is usually worse than that of the lower limb.  
 
 
25 
 
 
 
 
Posterior cerebral artery syndrome 
Signs and symptoms Structures involved 
a.Homonymous hemianopia  Calcarine cortex  
b.Cortical blindness, denial of blindness, 
apraxia of ocular movements  
Bilateral occipital lobe involvement  
c.Dyslexia without agraphia Dominant calcarine lesions  
d.Memory defect  Dominant temporal lobe  
 
Vertebral artery Occlusion  
Wallenberg's syndrome occurs due to the Posterior inferior cerebellar artery 
occlusion (PICA), vertebral, or superior, middle or inferior lateral medullary 
arteries. This syndrome is characterized by contralateral impaired pain and 
temperature sensation (spinothalamic tract involvement) and the same side 
numbness over half of the face, ataxia, Horner’s syndrome, dysphagia, vertigo, 
hiccups and loss of taste sensation.  
 
Basilar artery syndrome  
Complete basilar artery syndrome causing coma due to ischemia of high midbrain 
reticular activating system, quadriparesis along with facial involvement, 
ophthalmoplegia and loss of corneal and pupillary reflexes. Partial basilar artery 
syndromes will usually results in top-of-the-basilar syndrome, locked-in syndrome. 
26 
 
In locked in syndrome, the pathology is infarction of base of Pons resulting in 
quadriparesis along with loss of facial expressions, loss of horizontal eye 
movements. Consciousness is retained due to sparing of reticular activating 
system, with presence of vertical movement of eye. 
In top-of-the-basilar syndrome, the presenting clinical picture will be hemianopia 
or complete cortical blindness, amnesia vertical gaze palsies, and hallucinations. 
 
Single perforating artery Occlusion  
'Lacunar syndrome' occurs mainly due to the occlusion of one of many arterioles 
which arises perpendicularly from large parent artery to supply little areas in deep 
areas of brain and brain stem. Here, the affected individual will not have any 
features suggestive of aphasia, hemianopia, neglect and conjugate deviation of 
eyes
20
. 
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TABLE 5 LACUNAR STROKE TYPES 
 
Clinical features Structure involved 
 
Pure motor hemiparaesis 
 
Infarct in the basis pontis, posterior limb of 
Internal capsule, 
 
Pure sensory stroke 
 
Ventral thalamus infarct 
 
Ataxic  hemiparaesis 
 
Pons -Ventral portion  infarct 
 
Dysarthria and clumsy hand 
syndrome 
 
Genu of internal capsule infarct 
 
Pathophysiology 
Acute ischemic strokes result from vascular occlusion secondary to 
thromboembolic disease. Ischemia causes cell hypoxia and depletion of cellular 
ATP. Without ATP, theenergy to maintain ionic gradients across the cell 
membrane is lost leading to cellular depolarization. Cytotoxic edema results from 
influx of sodium and calcium ions and passive inflow of water into the cell
21, 22, 23
.  
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Ischemic core and penumbra 
An acute vascular occlusion produces heterogeneous regions of ischemia in the 
affected vascular territory. Affected regions with cerebral blood flow of lower than 
10 ml/100 g of tissue/min are referred to as the core. As the stroke begins the cells 
in ischemic core die within minutes
24
 . 
Affected regions with cerebral blood flow of lower than 25 ml/100 g of tissue/min 
are referred to as ischemic penumbra. Due to marginal perfusion for some hours, 
tissueviability is maintained
24
 . 
Ischemic cascade 
Due to depletion of ATP, membrane ion-transportsystem (sodium-potassium 
pump) fails resulting in intracellular increase in sodium, thereby increasing 
intracellular water content. This cellular swelling produces as cytotoxic edema and 
occurs very early in cerebral ischemia.  
Also the Cerebral ischemia impairs the normal sodium-calcium exchange protein  
resulting in calciuminflux , leading to release of neurotransmitters, such as  
glutamate, activating  N -methyl-D-aspartate (NMDA) and other excitatory 
receptors present in  neurons .  
29 
 
These neurons then become depolarized, causing more calcium influx, 
furtherreleasing glutamate, and local amplification of the initial ischemic insult 
occurs. Destruction of the cell membrane and other neuronal structures Occurs due 
to activation of various derivative enzymes mediated by massive calcium influx
25. 
Generation of nitric oxide,arachidonic acid, and free radicals aggravates further 
neuronal damage.  
Within 4-6 hours after infarction,ischemiacauses breakdown of the blood-brain 
barrier. Following the barrier’s breakdown, proteins and water passes into the 
extracellular space, causing vasogenic edema. This produces mass effect that peak 
at 3-5 days andover few weeks, with resorption of water and 
proteinsvasogenicedema resolves
26, 27
. 
Within hours to days after a stroke, cytokines formation takes place by activation 
of specific genes, whichcauses further inflammation and dysfunction of cerebral 
vasculature
25
.Ultimately, the ischemic penumbra is affected by these progressive 
insults, fusing with the infracted core, often within hours of the stroke onset.  
Infarction results in the death of astrocytes,the supporting oligodendroglial and 
microglia cells. The infracted tissue ultimately undergoes liquefaction necrosis and 
is removed by macrophages, with the reduction in parenchymal volume .As a 
result of encephalomalacia and cystic change, a well-circumscribed region of 
30 
 
cerebrospinal fluid–like low densityis seen. These chronic changes usually seen in 
the weeks to months following the infarction. 
Hemorrhagic transformation  
Hemorrhagic transformation represents the conversion of an ischemic infarction 
into an area of hemorrhage. In the absence of fibrinolytic treatment the incidence is 
5% in uncomplicated ischemic strokes. Worsening of Neurologic deficit will not 
be always associated with hemorrhagic transformation .The changesinclude small 
petechial hemorrhages to the formation of hematomas which may need surgical 
evacuation or decompressivehemicraniectomy.  
Mechanisms for hemorrhagic transformationinclude reperfusion of ischemic tissue 
occurring due to 
i. Recanalization of an occluded vessel,  
ii.Formation of collateral blood supply around ischemic area, 
 iii. Blood-brain barrier disruption. 
Red blood cells extravasateto produce petechial hemorrhage to frank 
hematoma
21,28, 29.
 
31 
 
Hemorrhagic transformation of an ischemic infarct occurs within 2-14 days post 
ictus, oftenwithin a week of event. It  common occurs  
a).After cardioembolic strokes 
b).with larger infarct strokes,
30, 21, 31 
c).following administration of rt-PA in patients whose noncontrast CT (NCCT) 
scans suggestive of ischemic stroke
32, 33, 34
. 
Post stroke cerebral edema and seizures 
Edema and herniation are the most common causes of early death in patients with 
hemispheric stroke.Seizures occur in 2-23% of patients within the first few days 
after ischemic stroke 
35
. Stroke also causes chronic seizure disorders infraction 
ofpatients. 
Embolic strokes 
Cardiogenic emboli account for up to 20% of acute strokes
36
. 
Commonly emboli arise from  
Valvular thrombi (mitral stenosis,endocarditis, from use of a prosthetic valve) 
 Mural thrombi  (AMI , DCM ,AF,CCF) 
32 
 
 Atrial myxoma 
 Right-sided circulation (paradoxical emboli) with passage through a PFO. 
 Extra cranial arteries. 
Acute myocardial infarction (AMI) is associated with a 2-3% incidence of embolic 
strokes, of which 85% occur after the first month of myocardial infarction
37
. 
Embolic strokes have a sudden onset, with neuroimagingshowing infarcts in 
several vascular territories or calcific emboli.  
Cardioembolic strokes may occur as isolatedor multiple in a hemisphere, or 
scattered and bilateral; the last two types indicate multiple vascular distributions 
and are more specific for cardioembolic stroke. Other causes include emboli 
originating from the aortic arch and diffuse thrombotic or inflammatory processes 
that can lead to multiple small-vessel occlusions. 
Thrombotic strokes 
Thrombosis results from injury to and loss of endothelial cells which exposes the 
subendothelium inturn activating platelet, clotting cascade, inhibition of 
fibrinolysis, and finally stagnation of blood. Thrombotic strokes usually originate 
from ruptured atherosclerotic plaques. Turbulent blood flow causes stenosis in the 
arteries, which favors thrombusformation; atherosclerosis (i.e., ulcerated plaques); 
33 
 
and platelet adhesion. Thus blood clot formed either embolizes or occlude the 
artery.  
Because of widespread atherosclerosis,thrombotic stroke also results due to 
intracranial atherosclerosis. In younger patients, the causes includes, 
21, 38
 . 
 Hypercoagulable states  
 Sickle cell disease 
 Fibro muscular dysplasia 
 Arterial dissections 
 Vasoconstriction due to substance abuse (e.g., cocaine, amphetamines). 
 Lacunar strokes 
Lacunar strokes represent 13-20% of all strokes caused by ischemia. They occur 
due to occlusion of the middle cerebral arteries penetrating branches, the 
lenticulostriate arteries, or circle of Willis, vertebral artery, or basilar artery 
penetrating branches,. They mostly related to hypertension. 
 Lacunar infarct causes includes: 
 Microatheroma 
 Lipohyalinosis 
 Fibrinoid necrosis as a result of hypertension or vasculitis 
34 
 
 Hyaline arteriosclerosis 
 Amyloid angiopathy 
 Microemboli 
 
Watershed infarcts 
Vascular watershed or border-zone infarcts areinfarction occurring between arterial 
territories at the most distal areas. They are secondary to embolic phenomenon or 
to decreased blood flow
39, 40, 41
 . 
Flow disturbances 
 Inadequate cerebral blood flow  results in stroke symptoms because of decreased 
blood pressure (and specifically, decreased cerebral perfusion pressure) or as a 
result of hematologic hyperviscosity from sickle cell disease or other hematologic 
illnesses, such as multiple myeloma and polycythemia vera. 
IMAGING STUDIES  
CT SCAN 
CT scan helps in the clear differentiation between hemorrhages and infarct and it 
also helps to detect abscess, tumor mass lesions, extraparenchymalhemorrhages 
(Extra Dural and Sub Dural hemorrhages) 
11.
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Merits:  
1. CT distinguishes infarct and hemorrhages and helps the treating physician 
to decide the line of management. .  
2. CT scans are highly sensitive in detecting Subarachnoid Hemorrhage.  
Demerits:  
1. When CT scans are taken in an acute set up, CT scans will not usually  
detect the infarct in the first 24 to 48 hours.  
2. CT scans misses the small infarct on the cortical surface.  
3. Usually CT scans will not detect the posterior fossa lesions due to artifact 
(bone).  
INFARCT: Infarct is evident as hypo dense lesion in CT scan. Hypo dense 
marking of particular vein, gray enhancement and post contrast enhancement of 
that particular vein in CT scans favors thrombosis of cortical veins of the brain.  
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Fig 1 .Ischemic stroke- hypo dense lesion 
HEMORRHAGE: A hyper dense area in the film indicateshemorrhages. About 
1cm or more in diameter hemorrhages will be detected in CT scans.  
 
Fig 2 . Hemorrahagic stroke -hyper dense lesion 
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TABLE 6 CT FINDING IN CEREBRAL INFARCTION
42
 
Timing of Infarct CT Findings 
a.Hyperacute (<12 hours)  Lentiform Nucleus obscuration  
Increased dense lesions (25 – 50 %)  
Normal (50%)  
b.Acute (12 to 24 hours)  Effacement of sulcus,loss of grey and 
white matter differentiation (Insular 
ribbon sign ) 
 
c.Days 1day to 7 days 
Transformation of infarct into 
hemorrhages, Enhancement of Gyrus, 
Mass effect, Low density areas which is 
wedgeshaped, involving white and 
greymatter. 
d.Weeks :1-8  Resolving of mass effects, persistence 
of contrast enhancement.  
e.Months to years 
 
Encephalomalacia changes. Loss of 
Volume  
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MRI SCAN 
11
 
 
1. Posterior fossa infarction and cortical infarction can be easily identified in these 
scans and so it was considered superior and more sensitive than CT scans in such 
lesions. 
2. Early brain infarction can be easily determined by Diffusion weighted images 
and this imaging modality is more sensitive.  
3. Stenosis of intracranial vessels and extracranial internal carotid arteries stenosis 
were detected by MR Angiogram.  
COMPLICATIONS OF STROKE 
12 
1. Aspiration Pneumonia 
2. Urinary tract infection  
3. Bed sores 
4. Pulmonary embolism with Deep vein thrombosis 
5. Contractures 
6. Dehydration 
7. Hypoxemia  
8. Hyperglycemia 
9. Frozen Shoulder and subluxation  
10. Constipation  
11. Hyponatremia and seizures
12.
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TREATMENT  
The laboratory investigation and treatment of stoke should be done in proper order 
as soon as clinical diagnosis of stoke is made.  
Goal of treatment: prevention of brain injury or reversal of ischemic brain damage.  
General treatment strategies of Stroke treatment  
1. Risk factors for Stroke should be controlled, in order to prevent further 
cerebrovascular accidents.  
2. Prevent stroke complications.  
3. Specific pathology and patho-physiologies should be treated 
43
. 
4. Airway should be secured, breathing and circulation should be maintained.  
5. Blood sugar should be maintained within normal limits.  
6. Emergency non contrast Computed tomography films should be taken, since it 
helps to distinguish between ischemia and hemorrhage.  
7. Points that favors Hemorrhagic stroke at that the time of presentation were 
initial maximum deficit, altered or diminished level of consciousness and increased 
blood pressure and the points that denotes infarct were maximal at onset or remits 
after onset 
12
. 
8. Promotion of recovery of stroke patients.  
9. Improve neurological function.  
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TREATMENT CATEGORIZATION 
12 
 
1. Medical therapy  
 
2. I.V. thrombolysis  
 
3. Anti thrombotic treatment  
 
4. Endovascular techniques  
 
5. Neuroprotection 
 
6. Stroke rehabilitation  
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Medical management  
 
Aim of therapy:  
 
To restore blood flow around ischemic penumbra. 
 
1. I.V mannitol: Cerebral edema usually peaks around 2nd to 3rd day and it will 
last for 10 days, so I.VMannitol should be given in order to reduce cerebral edema. 
If it is not treated, it will result in herniation of the brain and finally it leads to 
sudden cardio-respiratory arrest and in such cases Hemi-craniotomy, where part of 
the skull can be removed temporarily.  
 
2. Blood pressure monitoring and its reduction is necessary only when there is 
a).Associated myocardial infarction 
b).The patient is planned for thrombolytic therapy (>185/110mmHg) 
c). Hypertensive emergencies.  
3. Deep vein thrombosis prophylaxis should be given, by adding Subcutaneous 
Heparin (Unfractionated Heparin) 
4. Heart rate reduction should be done with β1blocker Esmolol, which helps to 
restore maintain the mean arterial pressure to brain.  
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5. Hyperthermia should be treated with cooling blankets.  
6. Blood sugar monitoring should be done since hyperglycemia results in poor 
outcome and it should be maintained around 110mgs/dL 
12 
. 
 
I.V. Thrombolysis  
Recombinant tissue plasminogen activator (rt-PA) is now used as a thrombolytic 
agent of choice. The incidence of intracranial hemorrhage is minimal with this 
drug. The time window period for administering rt-PA in patients with ischemic 
stroke is 3 hours but it can be extended up to a maximum of 6 hours. The 
recommended dose of rt-PA is 0.9 mg /kg and the maximum dose of this drug is 90 
mg. 10% of the drug should be given as i.v. bolus and remainder as intravenous 
infusion over a period of one hour. Frequent monitoring of blood pressure is 
necessary while administering this drug, and  should be stopped once patient 
develops signs of neurological deficit and in such case cryoprecipitate should be 
administered. Urinary catheterization should be avoided for another 2 hours 
12.
 
Indications for thrombolysis  
1. Clinical diagnosis of stroke.  
2. Patient should remain in the category of therapeutic window  
period of 3 hours.  
3. There should not be any evidence of hemorrhage or  infarct that  
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involves more than 1/3 of involved  territory, mass effect or edema in CTscan 
4. Patient should be >18years.  
5. Consent by patient attenders’12 
Contra indications for thrombolysis  
1. BP >185/110 mmHg in spite of treatment.  
2. Patient having completed stroke in last 14 days or symptoms suggestive of TIA 
3. Patient presenting with any upper and lower Gastrointestinal bleeding in  
previous 3 weeks,  
4. Recent myocardial infarction,  
5. Platelets < 1 lakhs / cu.mm; PCV < 25%; Glucose <50 or >400 mgs /dL.  
4. Heparin should not be used in preceding 48hours and elevated  
aPTT / INR.  
6. Prior stroke or head trauma in last 90 days or prior intracranial  
    hemorrhage.  
7. When patient consciousness is lost (in comatose state) or  
   Patientremaining in a stuporus condition.  
 
ANTITHROMBOTIC TREATMENT  
 
Platelet inhibition: Thrombaxane A2 is prostaglandin, which is a platelet 
aggregator as well as vasoconstrictor. Aspirin acetylates the cyclooxygenase of 
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platelets and completely inhibits the platelet plug formation .This platelet plug 
inhibition is irreversible. The anti-platelet activity of acetyl salicylic acid will 
remain for at least 8 days. Low dose aspirin should be given as once daily dose. It 
will inhibit only thromboxane A2 production and the inhibition of prostacyclin is 
spared. So generally recommended dose for stroke is 50-325 mg/day 
12.
 
 
ANTICOAGULATION  
Anticoagulation should be advised for all patients with atrial fibrillation due to non 
valvular heart disease and cardiac disease. Cerebral embolism can be prevented by 
maintaining INR between 2-3.Vitamin K antagonists effectively brings out this 
anticoagulation. 
Indications of anticoagulation for 3 months include: 
1. Left ventricular dysfunction  
2. Atrial fibrillation  
3. Anterior Q –wave infarction  
4. Mural thrombus  
5. Congestive cardiac failure  
ENDOVASCULAR TECHNIQUES  
Endovascular techniques should be planned for all patients for whom thrombolysis 
failed & thrombolysis contraindicated .These candidates were eligible for 
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endovascular mechanical thrombectomy. And by this procedure, blood flow to the 
occluded vessels can be established within 8 hours of stroke 
12
.  
 
NEUROPROTECTION  
Neuroprotective drugs blocks the neuro- excitatory amino acid pathway and it 
promotes the tolerance of brain to ischemic effects. Some of the drugs which give 
neuroprotection are Calcium Channel Antagonists (e.g., flunarizine, and 
darodipine), Non competitive N-methyl–D-aspartate receptor antagonists (e.g., 
dextromethorpan, eliprodil) and Phosphatidyl choline synthesis (e.g.Citicoline) 
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STATINS  
 
Satins are the inhibitors of 3-hydroxy -3 methylglutarylcoenenzymeAreductase 
inhibitor. These drugs were effective in reducing the cholesterol levels particularly 
low density lipoproteins. And it was found very effective in reducing the incidence 
of Coronary artery disease and cerebrovascular accidents.  
These statins has the following properties:  
1. Normalizes the vascular endothelium  
2. Reducing inflammation  
3. Stabilizes the plaques mainly the central lipid core mass.  
46 
 
4. Reduces the platelet-fibrin thrombi and decreases white clots deposition on the 
endothelial surfaces.  
5. Fibrous caps of atheromatous plaques get strengthened and stabilized.  
6. Thrombogenicity of the atheromatous plaques gets decreased 
43.
 
 
 
STROKE REHABILITATION  
a) Speech therapy  
b) Occupational therapy  
c) Physical therapy  
d) Pharmacological therapy 
12. 
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ACUTE PHASE REACTANTS  
 
In 1941, Avery and Theodore J Abernethy coined the term Acute Phase Reactants.  
Acute phase reactants are the markers of inflammation and they are elevated in 
inflammation, infection and they tend to appear or rise in the blood whenever the 
immune system comes in contact with proteins. This elevation of acute phase 
reactants indicates inflammatory burden and it gets elevated in vascular events 
44
.Some of the acute phase reactants are  
TABLE 7 ACUTE PHASE REACTANTS 
a. α1 globulin  
  b. α2 globulin  
  c. α1antitrypsin 
  d. Fibrinogen 
e.Fibrinonectin 
  f. Serum Amyloid A protein 
g. Pre-Albumin  
  h. Ferritin 
i. Transferrin 
 
Among these reactants, Pre-Albumin, Transferrin were negative phase reactants, 
they tend to decrease during inflammatory reactions whereas others increase 
during any inflammatory and infective conditions
45
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Genetics, Inflammation and CVA 
Atherosclerosis considered as chronic, dynamic, inflammatory condition 
caused by a response to endothelial injury. 
Risk factors such as oxidized low-density lipoprotein (LDL) cholesterol, smoking 
and infections contribute to this injury and atherosclerosis. Host genetic factors 
modify the response to these environmental insults, although inherited risk for 
stroke is likely multigenic.   
Mutations of number of genes are known to increase susceptibility to ischemic 
stroke. 
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TABLE 8 GENES SUSCEPTIBILITY TO  STROKE 
F2and F5 genes Increase the risk of thrombosis. 
NOS3Nitric oxide synthetase gene 
vascular relaxation mechanism 
47
 
ALOX5AP Arachidonic acid metabolism
48
 
PRKCH 
Major signal transduction 
systems
49
 
MTHFR 
(5,10-Methylenetetrahydrofolate reductase 
gene) 
Hyperhomocysteinemia 
CBS (cystathione beta synthetase) gene homocystinuria 
CST3 gene Amyloid angiopathies 
NOTCH3 gene 
Cerebral arteriopathy, 
autosomaldominant, with sub 
cortical infarcts 
,leukoencephalopathy 
(CADASIL) 
2 single-nucleotide polymorphisms on 
2q23.3 
Early onset ischemic stroke 
HDAC9, PITX2, and ZFHX3 genes Large-vessel stroke 
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The proposed mechanisms for role of inflammation in cerebrovascular disease are:  
a.Soon after an ischemic stroke, acute atherothrombotic event brings out an 
ischemic necrosis in acute cerebral infarction and brain damage.  
b.Formation of athermanous plaques and fatty streaks (atherosclerosis) is a  
Life long process.  
c.In intracerebral hemorrhage, brain injury is delayed.  
d. Sub-arachnoid hemorrhage causes vasospasm leading on to Cerebrovascular 
accidents.  
 
 
FERRITIN 
 
Ferritin is the cellular storage protein for iron.The principal factor that controls 
cellular ferritin content is the intracellular level of free iron. Thus, Ft provides a 
means of storing the metal within cells in available safe manner. Ferritin is also 
present at a very low concentration in blood but the role of circulating Ft is still 
unknown. However, serum Ft has been used widely in clinical medicine chiefly as 
an indicator of body iron stores.Itis an acute-phase reactant involved in cellular 
defense against oxidative stress and inflammation along with transferring 
50
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Fig 3 Synthesis and metabolism: 
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Iron is stored as hemosiderin (water-insoluble) or ferritin(water-soluble) inside the 
cell. Theypresent in all cells of the body, tissue fluids. By the action of enzymes 
present in lysosomes , ferritin  is converted into hemosiderin
51. 
Ferritin degradation 
within the cytosol results in complete release of the iron
52.
 
The normal range of ferritin includes: 
 Males: 30-300 ng/ml 
 Females: 10-200ng/ml 
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Indications: 
 To identify iron deficiency condition  and monitor  
 To see the  response to therapy or compliance with treatment 
 To distinguish iron deficiency from chronic disease as a cause of anemia. 
 To see the iron status in patients with renal diseases. 
 To study the iron level and its response to supplements in population. 
 To see the response to iron depletion therapy in iron overload states
53
.
 
TABLE 9 CONDITIONS WITH ALTERED FERRITIN LEVEL
 
Increased Decreased 
 Malignancies  Iron deficiency 
 Hyperthyroidism  Hemodialysis 
 Gaucher disease  
 Myocardial infection  
 Iron overload (hemochromatosis)  
 End-stage renal disease  
 Renal cell cancer  
 Anemia other than iron 
deficiency
[2] 
 
 
 Acute and chronic liver disease  
 Infection,inflammation,alcohol  
54 
 
 
Structure 
Ferritin (Ft) is a complex of iron with the protein apoferritin. It is composed of 24 
subunits of two types namely, high and light subunits also named as H and L 
chains. Its molecular weight corresponds to 440 kilodalton thatcan store up to 4500 
atoms of iron. 
Functions of ferritin: 
1. Iron storage. 
2. Ferroxidase activity. The heavy chain of ferritin which has ferroxidaseactivity is 
involved in the conversion of iron from the ferrous (Fe2+) to ferric (Fe 3+) forms. 
This limits the deleterious reaction which occurs between ferrous iron and 
hydrogen peroxide known as the Fenton reaction which produces the highly 
damaging hydroxyl radical. 
3. Immune response, infection, cancer increases the serum ferritin level. Endotoxin 
is anpositive regulator for the ferritin coding gene. 
4. Stressresponse. The concentration of ferritin has been shown to increase in 
response to stresses such as anoxia
54
 
5. Industrialapplications. Ferritin is also used in materials science as a precursor in 
making iron nanoparticles for carbon nanotube growth by chemical vapor 
deposition. 
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Free Radical Damage  
Three major molecular events involved in brain damage include calcium overload, 
acidosis, and increased production of free radicals. Production of free radicals are 
increased under ischemic conditionsdamage the proteins, nucleic acids and 
membrane lipidsaffecting the cellular integrity. This oxygen radical activity is 
more severe during reperfusion after sustained ischemia.  
Fenton reaction 
 
(1) Fe
2+
 + H2O2 +H
+
 → Fe3+ + HO• + H2O 
(2) Fe
3+
 + H2O2 → Fe
2+
 + HOO• + H+ 
Ferrous Iron (Fe
2+
 ) is oxidized by hydrogen peroxide (H2O2 ) to ferric iron( Fe
3+
), 
a hydroxyl radicaland a hydroxylanion.  Iron (III) is then reduced back to iron (II), 
superoxide radical and proton by the same hydrogen peroxide.  
Thus reactive hydroxyl radicals formed in the Fenton reaction interacts with lipids 
to initiate the formation ofoxidized LDL that finally leads to the development 
offoam cells and progression of atherosclerosis. Thus the sensitivity of neurons to 
oxidative stress depends on the availability of iron in the ischemic focus. Iron is 
released from large transport proteins, mainly from ferritin, which forms one third 
to three quarters of brain iron. In the absence of inflammation, infection andcancer 
the serum concentration of ferritin is found to be directly proportional to tissue iron 
stores and can be used to assess their infarct size.  
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Increased body iron stores  also cause progressing stroke by stimulating  the 
release of glutamate, which  triggers biochemical reactions that lead to brain cell 
death .Additionally  iron  also plays a role in vascular disease by activating 
platelets via a protein kinase C mechanism. 
3. Another proposed mechanism by which iron may play arole in ischemic vascular 
disease, is through reperfusion injury. After the event of ischemic stroke, 
reperfusion causesmarked increase in oxygen-radical production as well as a 
release of iron ions, causing further tissue damage and cellular death. 
4. As stroke specificareasare rich in iron, high amounts ofPUFA side chains in 
membrane lipids and low amountof antioxidant enzymes such as 
glutathioneperoxidase,superoxide dismutase,and catalase the brain tissues are 
vulnerable to oxidative stress. 
Prognostic significance of serum Ferritin in Acute Ischemic Stroke 
Recent animal experiments have suggested that iron overload contributes to the 
development of vascular diseases by promoting thrombosis after arterial injury 
supported by study done by  Day et al, 2003.High serum Ft on admission of acute 
stroke patients (within 24 to 48 h after stroke onset) was reported to predict a bad 
prognosis supported by Davaloset al, 1994, 2000; Erdemoglu and Ozbakir, 
2002studies, implicating  that increase in body iron stores before stroke onset can 
aggravate the cytotoxicity of brain ischemia. 
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NATIONAL INSTITUTE OF HEALTH STROKE SCALE (NIHSS) 
 
 NIHSS was developed to asses the impairment caused by a stroke. NIHSS is 
composed of 11 components, each of which scores a specific ability between a 0 
and 4. A score of 0 indicates normal function, while a higher score is indicative of 
impairment
55 
.Total scores range from 0-42 with higher values  
Representingmore severe infarcts. 
1. Cranial Nerve/ Visual disturbances  
2. Level of Consciousness  
3. Motor weakness  
4. Language/ Neglect – were the four important areas to be taken into account. 
Even based on this clinical parameter, scores can be computed and severity can be 
assessed. 
 
Merits of NIHSS  
 
a. Helps in diagnosing Cerebrovascular accidents.  
b. To know the prognosis of stroke  
c. To determine functional disability  
d. Rapid way of assessing the patient, which can be done in 10 minutes. 
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TABLE 10 NIHSS  
Tested Item  Title Response & Scores  
1A  Level of 
Consciousness  
0 – Patient is very alert  
1 – Ready to fall asleep, lack of attention, 
patient will respond to painful stimuli  
2 – Patient is not alert or oriented to time, 
person, place and remains in a state of 
confusion or frank delirium  
3 – Patient is Comatose and not 
responding to painful stimuli  
1B  Orientation Questions  0 – Here patient answers correctly to 2 
simple questions. 
1 – Patient will answer 1 question 
correctly  
2 – Patient will not answer correctly to 
any question. 
1C Response to 
Commands  
0 – Patient will do both work and tasks 
perfectly  
1 – Patient will do one task perfectly  
2 – Patient will not do both tasks  
59 
 
2 Gaze  0 – Patient has normal horizontal 
movements  
1 – Patient can have gaze palsy which is 
partial  
2–Complete ophthalmoplegia 
 
3 
Field of vision 0 – Patients visual field is normal  
1 – Patient will have Hemi-anopia which 
is partial  
2 – Patient will have Hemi-anopia which 
is complete  
3 – Here Hemi-anopia is bilateralation 
4 Facial Movements 0 – Normal  
1 – Here facial palsy is subtle  
2 – Patient will have facial weakness 
which is incomplete  
3 – Here facial palsy is complete which is 
unilateral 
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5 Motor Functions  
(Arm)  
 
a) Left  
 
b) Right  
 
0 – No fall when both forearms are 
stretched out and kept in supinated 
position for 10 sec 
1 – Fall of forearm and hand occurs but 
does not hit the bed 
2 – Forearm and hands fall and hits the 
bed 
3 – No movement against gravity  
4 – Total paralysis 
6 Motor Functions  
(leg)  
 
a) Left  
 
b) Right  
0 – No fall of leg for 5sec 
1 – Fall of leg occurs but it doesn’t hit the 
bed. 
2 – Fall of leg occurs and  hits the bed.  
3 – No movement against gravity  
4 – Total paralysis 
7 Limb Inco-ordination 0 – Normal  
1 – Inco-ordination of only one limb  
2 – Inco-ordination of two limbs 
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Interpretation of NIHSS Score  
 
0 – No stroke  
1-4 – Minor stroke  
5-15 – Moderate stroke  
16-20 – Moderate to severe stroke  
21-41 – Severe stroke 
8 Sensory  
 
0 – Patient will not have any sensory loss  
1 – Here sensory loss is mild  
2 – Here patient will have severe sensory 
loss 
9 Language 0 – Patient can communicate and 
comprehend the language properly 
 
10 
Articulation 0 – Normal  
1 – Articulation defect is mild  
2 – Articulation defect is severe 
11 Extinction or 
inattention 
(Neglect) 
0 –  Normal 
1 – One modality of sensation is loss  
2 – Severe loss of sensation  
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Modified Rankin Scale (MRS) 
Parameters: MRS carries a total score of 0-6.  
TABLE 11 MRS 
Score Observations 
0 Patient should not have any symptoms at all 
1 
Patient should not have any significant disability in spite of 
presence of symptoms and can able to perform routine daily normal 
activities 
2 
Patient will have slight disability and the person cannot perform all 
routine activities but manages to do his personal work without help 
 
3 
Patient is having moderate disability and needs some help, but able 
to walk without assistance. 
4 
Patient will have moderately severe disability and cannot walk 
without help and unable to do his personal affairs without 
assistance 
5 
Here patient is having severe disability and the affected individual 
is bedridden, urinary incontinence will be present and needs 
continuous nursing care and attention 
6 Dead 
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MATERIALS AND METHODS  
 
SETTING:  
Patients admitted in Medical wards, Kilpauk Medical College and Hospital, 
Chennai. 
 
COLABORATIVE DEPARTMENTS:  
Department of Biochemistry, Neurology, Radiology, Medicine, Kilpauk Medical 
College and Hospital. 
 
STUDY DESIGN:  
Cross sectional (Prospective)observation study  
 
PERIOD OF STUDY:  
March 2013 to October 2013 
 
STUDY POPULATION:  
60 Acute ischemic stroke patients admitted in medical wards, Kilpauk Medical 
College and Hospital. 
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DEFINITIONS FOLLOWED IN THIS STUDY:  
 
STROKE:  
As per WHO criteria, Acute Stroke is defined as “rapidly developing focal or 
generalized (for coma patients) neurological alterations in cerebral function with 
signs and symptoms lasting for more than 24 hours or leading on to death, without 
any apparent cause for stroke except vascular etiology. 
 
HYPERTENSION:  
Hypertension was defined as patients with previous record of at least 2 recordings 
of >140 / 90 mmHg or patients who are on regular intake of anti hypertensive 
medications.  
 
DIABETES:  
Diabetes was defined as patients with Random Blood Sugar of >200mg/dl, fasting 
blood sugar of >126 mg/dl, post prandial blood sugar of >200mg/dl or patients 
who are in need of regular intake of anti-diabetic drugs.  
 
DYSLIPIDEMIA:  
Dyslipidemia was defined as patients with Fasting Serum Cholesterol values of 
more than 220 mgs/dl. 
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NIHSS SCORE  
NIHSS scoring was made based on the clinical parameters. In this study, patients 
with a score of 1- 4 were considered as MILD, score 5-15 were considered as 
MODERATE, score >15 were considered as SEVERE category.  
 
MRS score 
MRS score of 3,4,5,6 were included under Good Outcome and scores of 1, 2 were 
considered as Poor outcome. 
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INCLUSION CRITERIA:  
1. All patients with new onset focal neurological deficit following ischemic stroke, 
presented within 48 hours of onset of stroke are taken into study.  
2. Patients >14 years and of both sexes are included in the study.  
3. Patients with new onset stroke with past history of hypertension, diabetes 
mellitus, dyslipidemeia, smoking, alcohol were included.  
EXCLUSION CRITERIA:  
1. Patients with age more than 80 years were excluded.  
2. Patients with malignancy and clinical findings and blood investigations  
Suggestive of infection were excluded.  
3. Individuals with Connective Tissue disorders and Rheumatic heart disease,  
Coronary Artery diseases were excluded.  
4. Patients with prior history of transient ischemic attacks or reversible  
 ischemic neurological deficit, cerebrovascular accidents were excluded 
5. Patients with features of hemorrhage such as subdural hemorrhage,  
Sub-arachnoidhemorrhage and intracerebral hemorrhage were excluded  
 with the aid of CT scan.  
6. History of recent surgery and trauma.  
7. CNS tumors.  
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ETHICAL CLEARANCE:  
Necessary ethical clearance was obtained from ethical committee, Kilpauk Medical 
College &Hospital, Chennai. 
STUDY METHODS:  
60 patients who had acute ischemic stroke were included for study. Those patients 
who got admitted within 24 hours of stroke onset only were taken for study. As 
soon as patient got admitted, verbal consent was obtained from patient or attenders. 
Then complete relevant medical history, neurological examination, routine blood 
and CT scan were done and all data were recorded in a standardized proforma.  
CT scan was taken to exclude the hemorrhagicstroke. Serum ferritin was taken as 
soon as patient got admitted in the hospital. National Institute of Health Stroke 
Scale (NIHSS) scoring was applied at the time of admission and these patients 
were grouped into mild, moderate and severe .  
These Acute ischemic stroke patients were treated according to standard treatment 
protocols. None of the patients in the study group were thrombolysed. Anti edema 
measures were adopted with either intravenous Mannitol or oral Glycerol. 
Modified Rankin Scale was applied to know the functional recovery of the patient 
after 4 weeks when patient is on follow up and attending the review op.  
 
 
 
 
 
68 
 
STATISCAL METHODS  
 
All the collected data were computed in master chart. Statically data analysis was 
done. Chi Square test, Mean, Standard deviation, ‘p’ values were calculated. A ‘p’ 
value less than 0.05 denotes significant relationship. Pearson’s r correlation test 
and scatter plot analysis were also done for given data. 
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RESULTS AND ANALYSIS 
 
SEX DISTRIBUTION  
 
Total number of patients in the study   =60 (100%) 
Number of malecases inthe study=     38 (63.33%)  
Number of femalecases in the study =     22 (36.67%)  
 
TABLE 12 SEX DISTRIBUTIONS 
 
SEX NO.OF CASES PERCENTAGE 
 
MALE 38 63.33% 
 
FEMALE 22 36.67% 
 
TOTAL 60 100% 
 
 
 
 
Fig 4 sex distribution 
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Sex vs.serum Ferritin   
 
Out of 38 male patients, number of male patients who had normal serum ferritin 
are 16(42.11 %) and the number of male patients who had highserum ferritin 22 
(57.89 %).  
And out of 22 female patients, 9(40.91%) female cases had normal serum ferritin   
and 13 (61.9%) female patients had high serum ferritin level. 
TABLE 13SEX vs.SERUM FERRITIN 
 
p value = 0.927 NOT SIGNIFICANT 
 
 
SEX 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
MALE 
 
COUNT 
 
 
16 
 
22 
 
38 
 
% 
 
42.11% 
 
57.89% 
 
100% 
 
FEMALE 
 
COUNT 
 
9 
 
 
13 
 
22 
 
% 
 
40.91% 
 
59.09% 
 
100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
  
% 
 
41.67% 
 
58.33% 
 
100% 
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The sex and serum ferritin correlation was statistically not significant. 
AGE DISTRIBUTION  
 
Out of 60 patients, 14(23.33%) patients were in the age group of ≤ 50 years and 
46(76.67%) patients were in the age group of ≥ 50 years.  
 
TABLE 14 AGE DISTRIBUTIONS 
 
 
AGE (IN YEARS) 
 
 
NO.OF PATIENTS 
 
≤ 50 
 
14 
 
 
≥ 50 
 
46 
 
 
TOTAL 
 
 
60 
 
 
 
 
Fig 5. Age distribution 
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AGE VS SERUM FERRITIN 
 
Out of 14(23.33%) patients who were in the age group of ≤ 50 years, 6 (42.86%) 
patients had normal serum ferritin and 8 (57.14%) patients had highserum ferritin.  
Out of 46 (76.67%) patients who were in the age group of ≥50 years, 19 (41.30%) 
patients had normal serum ferritin and 27(58.70%) patients had highserum ferritin. 
Table 15 AGE vs. SERUM FERRITIN 
 
AGE (IN 
YEARS) 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
≤  5 0 
 
 
COUNT 
 
 
6 
 
8 
 
14 
 
% 
 
42.86% 
 
 
57.14% 
100% 
 
         ≥  50 
 
COUNT 
 
19 
 
 
27 
 
46 
%  
41.30% 
 
 
58.70% 
 
100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
  
% 
 
41.67% 
 
 
58.33% 
 
100% 
 
p value =   0.918                      NOT SIGNIFICANT 
The correlationbetween Age andSerum ferritin was statistically insignificant 
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Fig 6.Age distribution 
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SMOKERS VS SERUM FERRITIN 
 
Serum ferritin profile was done in all 60 cases which include both smokers and non 
smoker’s .Out of 27 patients who are smokers, 14 (51.85%) patients had normal 
serum ferritin and 13 (48.15%) patients had highserum ferritin.  
Out of 33 patients, who are non smokers, 11(33.33%) patients had normal serum 
ferritin and 22 (66.67%) patients had highserum ferritin. 
TABLE 16 SMOKING vs. SERUM FERRITIN 
 
SMOKING 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
YES 
 
 
COUNT 
 
 
14 
 
13 
 
27 
 
% 
 
51.85% 
 
 
48.15% 
 
100 
 
NO 
 
COUNT 
 
11 
 
 
22 
 
33 
 
% 
 
33.33% 
 
 
66.67% 
 
100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
  
% 
 
41.67% 
 
 
58.33% 
 
100% 
p value =   0.236                      NOT SIGNIFICANT 
 
The correlation between smoking andserum ferritin was statistically insignificant. 
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Fig 7.Smoking vs Serum ferritin 
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ALCOHOLICS vs. SERUM FERRITIN 
 
In both alcoholics and non alcoholics, serum ferritin profile was done. The number 
of patients with normal serum ferritin were 19(54.29%) and highserum ferritin 
were 16(45.71%) among total 35 patients who were non alcoholics. 
The number of patients with normal serum ferritin were 6 (24.00%) and high 
serum ferritin were 19 (76.00%) among total 25 patients who were alcoholics. 
TABLE 17 ALCOHOLSvs. SERUM FERRITIN 
 
ALCOHOL 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
YES 
 
 
COUNT 
 
 
6 
 
19 
 
25 
% 24.00% 76.00% 100 
 
        NO 
 
COUNT 
 
19 
 
 
16 
 
35 
% 54.29% 45.71% 100 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
 
% 
 
41.67% 
 
 
58.33% 
 
100% 
p value =  0.038       SIGNIFICANT 
 
The correlation between Serum ferritin and Alcoholics was statistically significant. 
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DIABETICS vs. SERUM FERRITIN 
 
Serum ferritin values were correlated with both diabetics and non diabetics’ 
patients. Among 16 non diabetics, 11 (68.75%) patients had normal serum ferritin   
and 5 (31.25%) patients had highserum ferritin. 
Among 44 diabetics, the numbers of patients with normal serum ferritin were 14 
(68.75%) and with highserum ferritin were 30 (66.7%). 
TABLE 18 DIABETES vs. SERUM FERRITIN 
 
DIABETES 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
YES 
 
 
COUNT 
 
 
14 
 
30 
 
44 
% 31.82% 68.18% 100 
 
        NO 
 
COUNT 
 
11 
 
 
5 
 
16 
% 68.75% 31.25% 100 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
% 41.67% 58.33% 100% 
 
p value =  0.023                       SIGNIFICANT 
 
The correlation between Serum ferritin and Diabetes was significant statistically. 
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Fig 8. Diabetes vs serum ferritin 
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HYPERTENSION vs. SERUM FERRITIN 
 
Serum ferritin   values were correlated in both hypertensive and nonhypertensive 
patients. Out of 21 non hypertensive patients, 13 (61.90%) patients had normal 
serum ferritin and 8 (38.10%) patients had highserum ferritin .Out of 39 
hypertensive patients, 12 (30.77%) patients had normal serum ferritin and 27 
(69.23%) patients had highserum ferritin. 
TABLE 19 HYPERTENSION vs. SERUM FERRITIN 
 
HYPERTENSION 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
YES 
 
 
COUNT 
 
 
12 
 
27 
 
39 
% 30.77% 69.23% 100% 
 
            NO 
 
COUNT 
 
13 
 
 
8 
 
21 
% 61.90% 38.10% 100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
 % 41.67% 58.33% 100% 
 
p value =    0.040                      SIGNIFICANT 
 
The correlation between serum ferritin and hypertension was statistically 
significant. 
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Fig 9. Hypertension vs Serum ferritin 
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CHOLESTEROL vs. SERUM FERRITIN 
 
Serum ferritin   profile was seen in both dyslipidemic and non dyslipidemic 
patients. Among 34 non dyslipidemic patients, 16(47.06%) had normal serum 
ferritin and 18(52.94%) patients had highserum ferritin. 
Among 26 dyslipidemic patients, 9(34.62%) had normal serum ferritin and 
17(65.38%) patients had highserum ferritin. 
TABLE 20 CHOLESTEROL VS. SERUM FERRITIN 
 
CHOLESTEROL 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
YES 
 
 
COUNT 
 
 
9 
 
17 
 
26 
% 34.62% 65.38% 100% 
 
             NO 
 
COUNT 
 
16 
 
 
18 
 
34 
% 47.06% 52.94% 100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
 % 41.67% 58.33% 100% 
 
p value = 0.481                  NOT SIGNIFICANT 
 
The correlation between Serum ferritin and Cholesterol was statistically not 
significant 
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Fig 10. Cholesterol vs Serum ferritin 
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LOSS OF CONSCIOUSNESS VsSERUM FERRITIN 
 
In Patients with loss of consciousness, serum ferritin    profile was done. The 
number of patients with normal serum ferritin   were 24 (51.06%) and highserum 
ferritin were 15 (48.94%) among conscious patients.  
The number of patients with normal serum ferritin were 1 (7.69%) and highserum 
ferritin were 13 (92.31%) among un-conscious patients.  
TABLE 21 LOSS OF CONCIOUS vs. SERUM FERRITIN 
p value =    0.013                      SIGNIFICANT 
The correlation between Serum ferritin and Unconscious patients was statistically 
significant. 
 
LOSS OF 
CONCIOUS 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
YES 
 
 
COUNT 
 
 
1 
 
12 
 
13 
%  
7.69% 
 
 
92.31% 
 
 
100% 
 
        NO 
 
COUNT 
 
24 
 
 
23 
 
47 
%  
51.06% 
 
48.94% 
 
100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
 % 41.67% 58.33% 100% 
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Fig 11. Loss of conscious vs. Serum ferritin 
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DESCRIPTIVE STATISTICS  
 
 The maximum and minimum mean values of serum ferritin   in the study are 
462.12 and 26.48 with an average mean of 241.39.  
The maximum and minimum mean values for NIHSS scoring system in the study 
is 23 and 5, with an average mean of 14.42. 
The maximum and minimum mean values for MRS scoring system in the study is 
6 and 1, with an average mean of 3.42.  
From this, it is evident that patients with a minimum serum ferritin   mean value of 
26.48 had  
a) NIHSS score minimum mean value of 5 which comes under moderate group and  
b) MRS minimum mean value of 1 which comes under good outcome.  
And patients withserum ferritin   maximum mean value of 462.12 had  
a) NIHSS maximum mean value of 23 which comes under severe category  
b) MRS maximum mean value of 6 which comes under poor outcome.  
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TABLE 22 DESCRIPTIVE STATISTICS 
VARIABLES  No.  MINIMUM  MAXIMUM  MEAN  STD. 
DEVIATION 
 
SERUM 
FERRITIN 
 
60 
 
26.48 
 
462.12 
 
241.39 
 
120.16 
 
NIHSS.SCORE 
 
60 
 
5 
 
23 
 
14.42 
 
6.31 
 
MRS.SCORE 
 
60 
 
1 
 
6 
 
3.42 
 
1.44 
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NIHSS DESCRIPTIVE STATISTICS  
 
Out of total 60 acute ischemic stroke cases, 38 (63.33%) patients come under 
moderategroup of under NIHSS scoring system.  
And 22 (36.67%) patients come under severity group of severe under NIHSS 
scoring system.  
 
 
TABLE 24 NIHSS DESCRIPTIVE STATISTICS 
 
NIHSS FREQUENCY PERCENT VALID 
PERCENT 
CUMULATIVE 
PERCENT 
MODERATE 38 63.33 63.33 63.33 
SEVERE 22 36.67 36.67 100.00 
TOTAL 60 100 100 100 
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SERUM FERRITIN vs. NIHSS  
 
Serum ferritin   profile was done in all patients and it was summated with various 
scoring categories of NIHSS. Out of 38 cases thatcome under moderate category in 
NIHSS, 25(65.79%) cases had normal serum ferritin  values and 13(34.21%) cases 
had high serum ferritin. Out of 22 cases that were under severe category, no cases 
had normal serum ferritin   and 22 (100%) cases had high serum ferritin.  
TABLE 25SERUM FERRITIN vs. NIHSS 
 
 
NIHSS 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
MILD 
 
 
COUNT 
 
 
0 
 
0 
 
00 
% 0 0 00 
 
        
MODERATE 
 
COUNT 
 
25 
 
 
13 
 
38 
% 65.79% 34.21% 100% 
 
SEVERE 
 
COUNT 
 
00 
 
22 
 
22 
 
 % 00 100% 100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
 % 41.67% 58.33% 100% 
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PEARSON’S r CORRELATION AND SCATTER PLOT ANALYSIS  
This table denotes strong correlation between serum ferritin   and NIHSS score. 
Change inserum ferritin values correlates with change in NIHSS scores.  
There is also positive correlation between NIHSS score and serum ferritin  , that is 
any increase in serum ferritin   will increase NIHSS scores and decrease in serum 
ferritin  values will decrease NIHSS scores. 
TABLE 16 SERUM FERRITIN vs. NIHSS 
 
  Serum ferritin NIHSS 
 
 
 
Serum ferritin 
PEARSON 
CORRELATION 
 
1 
 
0.613 
P VALUE   
0.000 
N 60 60 
 
 
 
NIHSS 
PEARSON 
CORRELATION 
 
0.613 
 
1 
P VALUE 
 
0.000  
N 60 60 
 
 
p value = .000                                          SIGNIFICANT 
 
There was statistically significant correlation between Serum ferritin and National 
Institutes of Health Stroke Scale. 
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PEARSON’S r CORRELATION AND SCATTER PLOT ANALYSIS  
 
Scatterplot analysis reveals that there is a positive correlation between serum 
ferritin   values and NIHSS scores. Increase in serum ferritin   increases with 
NIHSS scores. 
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MODIFIED RANKIN SCALE  
 
Among 60 total cases of stroke, 22 (40%) patients comes under good outcome by 
MRS scoring system and 38 (60%) patients comes under poor outcome by MRS 
scoring system.  
 
TABLE 17 MODIFIED RANKIN SCALE DESCRIPTIVE STATISTICS  
 
MRS  FREQUENCY  PERCENT  VALID 
PERCENT  
CUMULATIVE 
PERCENT  
GOOD  22 36.67 36.67 36.67 
POOR 38 63.33 63.33 100.00 
TOTAL  60 100 100 100 
 
 
 
 
SERUM FERRITIN vs. MODIFIED RANKIN SCALE  
 
Serum ferritin values were correlated with various outcomes in Modified Rankin 
Scale. Among 22 good outcome patients, 17 (72.27%) cases had normal serum 
ferritin values and 5(27.23% ) cases had high serum ferritin  .  
Among 38 poor outcome patients, 8 (21.05%) cases had normal serum ferritin and 
30 (78.95%) cases had high serum ferritin.  
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TABLE 18 SREUM FERRITIN vs. MODIFIED RANKINS SCALE 
 
MODIFIED 
RANKINS 
SCALE 
 
NO. OF 
 
PATIENTS 
 
SERUM FERRITIN 
 
TOTAL 
 
 
NORMAL 
 
HIGH 
 
GOOD 
 
 
COUNT 
 
 
17 
 
5 
 
22 
% 77.27% 22.73% 100% 
 
POOR 
 
COUNT 
 
8 
 
 
30 
 
38 
% 21.05% 78.95% 100% 
 
TOTAL 
 
COUNT 
 
25 
 
35 
 
60 
 
 % 41.67% 58.33% 100% 
p value =  0.000                                                      SIGNIFICANT 
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PEARSON’S r CORRELATION AND SCATTER PLOT ANALYSIS 
 
This table denotes correlation between serum ferritin and MRS score. Change in 
serum ferritin values strongly correlates with change in MRS scores.  
There is also positive correlation between MRS score and serum ferritin values that 
are any increase in serum ferritin   will increase MRS scores and decrease in serum 
ferritin   values will decrease MRS scores.  
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TABLE 19 SERUM FERRITIN vs. MODIFIED RANKINS SCALE 
   
Serum ferritin 
 
MRS 
 
 
 
Serum ferritin 
PEARSON 
CORRELATION 
 
1 
 
 
0.560 
P VALUE  
 
0.000 
N 60 60 
 
 
 
MRS 
PEARSON 
CORRELATION 
 
0.560 
 
 
1 
 
P VALUE 
 
 
0.000 
 
 
 
N 60 60 
 
The correlation between Serum ferritin and MRS scale was statistically significant. 
 
PEARSON’S r CORRELATION AND SCATTER PLOT ANALYSIS  
Scatterplot analysis reveals that there is a positive correlation between serum 
ferritin Values and MRS scores. Increase in serum ferritin   increases with MRS 
scores.  
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PEARSON’S r CORRELATION AND SCATTER PLOT ANALYSIS 
BETWEEN SERUM FERRITIN VALUES AND MRS SCORES 
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DISCUSSION 
 
Stroke is now considered as a major consequence of cerebrovascular accidents and 
health hazard to the society. In this study of prognostic significance of serum 
ferritin in Acute Ischemic Stroke consists of a group of 60 patients who were 
admitted in Kilpauk Medical College &Hospital,Chennaifrom March 2013 to 
October 2013. In this study, serum ferritin   was taken within 48 hrs and NIHSS 
scoring was applied on the day of admission.  
 
Totally 60 cases were included in the study. Among the 60 cases included in 
thisstudy  cases35(58.33%) had  high serum ferritin   values [≥ 300 mg/l (male) , 
≥200 mg/ml (female ) ] and 25 cases (41.67%) had normal serum ferritin  [≤ 300 
mg/l (male) , ≤ 200 mg/ml (female ) ]. Number of patients died in this group is 7. 
All these patients had a high serum ferritin.  
Out of these 35 cases thathave high serum ferritin, 37.14% of cases come under 
moderate category and 62.86% cases come under severe category. On the other 
hand, among the remaining 25 cases who had normal serum ferritin, all the 22 
cases come under moderate group and none in severe group.  
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Pearson’s r correlation also reveals positivecorrelation between serum ferritin   and 
NIHSS scores. Pearson’s r value is 0.613. A positive correlation exists between 
these 2 variables with a statistically significant ‘p’ value. 
Scatter plot analysis reveals the positive correlation between serum ferritin & 
NIHSS. Any increase or decrease in serum ferritin score analogous linearly with 
increase/decrease severity score of NIHSS.  
Out of 35 cases with high serum ferritin, 5 cases were in good outcome category 
and 30 cases in poor outcome category of MRS scores.  
In contrast among 25 cases with normal serum ferritin, 17 cases were in good 
outcome (MRS) and 8 cases were in poor outcome (MRS). Pearson’s r correlation 
analysis reveals positive correlation between serum ferritin and MRS. Pearson’s r 
value is 0.560 and is positive variable. Increase in serum ferritin will favors the 
poor outcome of patients in terms of death and severe disability. 
Sex  
In the present study, incidence of stroke in male patients is 63.33% whereas in 
female patients it is 36.67%. This incidence data was supported by Thomas 
Kuruvillet al 
56
in which males has higher incidence than female. No significant 
relationship exists between Sex and serum ferittin in the present study. This result 
is against the findings of Zacharski et al.The reason for this contradiction may be 
small sample size (only 60 cases considered) .  
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Age  
 
In the present study, incidence of stroke is more common among patient with the 
age group of more than 50 years. There is no significant correlation between serum 
ferritin and age, which was supported by study JHematolet al. 
Smoking  
 
In this present study, there is no significant correlation between serum ferritinand 
smoking with a p-value of 0.236. This was supported by study Salonen JT al.  
Alcohol 
In ourstudy there is correlation between alcohol and serum ferritin. Effect of 
alcohol consumption on indices of iron stores and of iron stores onalcohol intake 
supported byfollowing studies, which showed there is definite correlation between 
alcohol and Serum Ferritin. 
Studies in favor of alcohol increases Serum Ferritin level 
 
S.No Studies Year 
 
1. 
 
Leggett BA et al. 
 
 
1990 
 
2. 
 
Milman N&Kirchhoff M 
 
 
1996 
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Diabetes  
 
In this present study, there is significant correlation between Serum Ferritin and 
diabetes with a p-value of 0.023. This was supported by number of studies. 
Studies in favor of rise in blood sugar increases Serum Ferritin level 
 
S.No Study Year 
 
1. 
 
Fernandez et al 
 
2002 
 
2. 
 
Thomas MC et al 
 
2004 
 
3. 
 
Kim NH et al 
 
2000 
 
4. 
 
Eshed I et .al 
 
2001 
 
 
Hypertension  
 
In this present study, there is a significant correlation between Serum Ferritin and 
Hypertension with a p value of0.040. These findings are in agreement with 
following studies. 
Studies in favor of hypertension increases Serum Ferritin level 
 
S.No Study Year 
 
1. 
 
Wrede et al 
 
2002 
 
2. 
 
Piperno A et al 
 
2002 
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Cholesterol  
In the present study, there is a no significant correlation between serum ferritin and 
Serum Cholesterol level with a p value of 0.481. This findings were similar and in 
concordance with Halle M et al,Salonen JT et al. 
This study also demonstrates the significant correlation between serum ferritin  and 
cardiovascular risk factors such as diabetes, hypertension. Stroke is common in this 
risk groups and had significantly higher serum ferritin. 
Ferritin and out come 
This study demonstrates the prognostic significance of serum ferritin in acute 
ischemic stroke patients in correlation with stroke scores, which were measured at 
the time of admission (NIHSS) and four weeks after discharge. (MRS).Our study 
concludes that raised Serum Ferritin is associated withpoor prognosis. There are 
other studies favoring this fact.Studies favoring Prognostic Significance of 
serum ferritin in Acute Ischemic Stroke are 
S.No Studies Year 
1. Daphne L et al 
 
2005 
2. Davalos A et al 
 
2000 
3. Fernandez – Real JM et al 
 
1994 
4. Erdemoglu AK et al 2002 
 
104 
 
CONCLUSION 
a.Thispresent study is a cross sectional observation study of prognostic 
significance of serum ferritin in acute ischemic stroke patients.  
b. The present study shows male predominance with majority of patients in the age 
group of greater than 50 years.  
c. The present study revealed significant association between serum ferritin and 
diabetes mellitus, hypertension & alcohol.  
d. This study demonstrates the significant rise in serum ferritin in ischemic stroke 
patients in correlation with high scores with NIHSS which indicates the severity.  
e. This study reveals the poor outcome in correlation with high serum ferritin 
values and good outcome in correlation with low serum ferritin values. .  
f. This study shows no statistically significant relationship between serum ferritin 
and age, sex andsmoking.  
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PROFORMA 
 
 
NAME: IP NO: SERIAL NO:  
AGE:  
SEX:  
OCCUPATION:  
ADDRESS:  
DATE AND TIME OF STROKE:  
DATE OF ADMISSION: 
STROKE: RISK FACTORS  
SYSTEMIC HYPERTENSION Y/N  
DIABETES MELLITUS Y/N  
SMOKING Y/N  
ALCOHOLISM Y/N  
HIGH CHOLESTEROL Y/N  
IHD Y/N  
RHD Y/N  
AF Y/N  
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PAST HISTORY OF STROKE :Y/N  
CLINICAL EXAMINATION:  
PULSE RATE: BP:  
CVS:  
RS:  
ABDOMEN:  
CNS:  
ACUTE STROKE SYMPTOMS AND SIGNS  
SYMPTOMS  
HEADACHE  
GIDDINESS  
LOSS OF CONSCIOUSNES  
VOMITING  
GAIT DISTURBANCE  
CONVULSIONS  
SPEECH DEFICIT  
SIGNS  
SPEECH DEFICIT  
HEMIANOPIA  
DIPLOPIA  
MOTOR SYSTEM  
PARESIS AT ANY SITE  
PARESIS OF ARMS Y/N R/L/B  
PARESI OF LEGS Y/N R/L/B  
PARESIS OF FACE Y/N R/L/B  
FIRST INVOLVED FACE / ARMS / LEGS  
NO SUCH ORDER Y/N  
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SENSORY DEFICIT Y/N  
CEREBELLAR SIGNS Y/N  
NIHSS SCORE AT THE TIME OF ADMISSION – MILD / MODERATE / 
SEVERE  
MRS AFTER 4 WEEKS: 00/01/02/03/04/05/06  
INVESTIGATIONS:  
HB%:  
TOTAL COUNT:  
DIFFERENTIAL COUNT P- , L- , E- , M- , B-  
ESR:  
HS-CRP:  
BLOOD UREA:  
BLOOD SUGAR:  
SERUM CREATININE:  
SERUM ELECTROLYTES:  
SERUM CHOLESTEROL:  
ECG:  
CT BRAIN:  
HEMORRHAGE: Y/N  
INFARCT: Y/N  
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MASTER CHART 
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Key words in master chart 
M- Male 
F- Female 
Y-Yes 
N- No 
LOC- Loss Of Conscious 
F-Facial Palsy (Column 10) 
V-Visual Disturbances 
SpDis- Speech Disturbances 
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ABBREVIATIONS 
1. C3,C4-Complements  
2. NIHSS-National Institute Of Health Stroke Scale 
3. MRS-Modified Rankin Scale 
4.TIA- Transient ischemic attack 
5.PICH- Primary intracerebralhemorrhage  
6.WHO- World Health Organization  
7.ICMR- Indian Council Medical Research  
8.GDP- gross domestic product  
9.DALY- Disability adjusted life-year 
10.UMN- Upper Motor Neuron  
11.ATP-Adenosine triphosphate 
12.NMDAN -methyl-D-aspartate  
13.AMI- Acute myocardial infarction  
13.AF-Atrial fibrillation 
14.CCF- Congestive cardiac failure 
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15.aPTT- Activated Partial Thromboplastin Time 
16. CT- Computed Tomography 
17. MRI- Magnetic Resonance Imaging 
18. CVA-Cerebrovascular Accidents 
19. MCA-Middle Cerebral Artery 
21. PCA- Posterior Cerebral Artery 
22. ACA- Anterior cerebral artery 
23. IHD – Ischemic heart disease 
24. RHD- Rheumatic Heart Disease 
25. DCM-Dilated cardiomyopathy 
26. rt-PA- Recombinant Tissue Plasminogen Activator 
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